Short-term oral treatment with the angiotensin II receptor antagonist losartan does not improve coronary vasomotor function in asymptomatic type 2 diabetes patients.
about
Mineralocorticoid receptors: an appealing target to treat coronary microvascular dysfunction in diabetes.The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice.Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus.
P2860
Short-term oral treatment with the angiotensin II receptor antagonist losartan does not improve coronary vasomotor function in asymptomatic type 2 diabetes patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Short-term oral treatment with ...... atic type 2 diabetes patients.
@en
Short-term oral treatment with ...... atic type 2 diabetes patients.
@nl
type
label
Short-term oral treatment with ...... atic type 2 diabetes patients.
@en
Short-term oral treatment with ...... atic type 2 diabetes patients.
@nl
prefLabel
Short-term oral treatment with ...... atic type 2 diabetes patients.
@en
Short-term oral treatment with ...... atic type 2 diabetes patients.
@nl
P2093
P1476
Short-term oral treatment with ...... atic type 2 diabetes patients.
@en
P2093
Birger Hesse
Hans-Henrik Parving
Ulrik Sloth Kristoffersen
P356
10.1016/J.DIABRES.2009.01.010
P577
2009-02-23T00:00:00Z